We are live on ! Find out more
HCA icon

HCA Healthcare

1,180 hedge funds and large institutions have $47.7B invested in HCA Healthcare in 2024 Q4 according to their latest regulatory filings, with 148 funds opening new positions, 399 increasing their positions, 468 reducing their positions, and 149 closing their positions.

New
Increased
Maintained
Reduced
Closed

1.52% more ownership

Funds ownership: 61.2%62.72% (+1.5%)

8% more call options, than puts

Call options by funds: $673M | Put options by funds: $624M

1% less first-time investments, than exits

New positions opened: 148 | Existing positions closed: 149

2% less funds holding

Funds holding: 1,2021,180 (-22)

15% less repeat investments, than reductions

Existing positions increased: 399 | Existing positions reduced: 468

26% less capital invested

Capital invested by funds: $64.1B → $47.7B (-$16.4B)

30% less funds holding in top 10

Funds holding in top 10: 4028 (-12)

Holders
1,180
Holders Change
-22
Holders Change %
-1.83%
% of All Funds
15.54%
Holding in Top 10
28
Holding in Top 10 Change
-12
Holding in Top 10 Change %
-30%
% of All Funds
0.37%
New
148
Increased
399
Reduced
468
Closed
149
Calls
$673M
Puts
$624M
Net Calls
+$48.6M
Net Calls Change
+$220M
Name Holding Trade Value Shares
Change
Change in
Stake
TSW
326
Thompson Siegel & Walmsley
Virginia
$5.86M +$1.22M +3,500 +22%
NCM
327
Narwhal Capital Management
Georgia
$5.85M -$1.3M -3,714 -16%
TFS
328
Thoroughbred Financial Services
Tennessee
$5.85M +$244K +697 +4%
Commonwealth Equity Services
329
Commonwealth Equity Services
Massachusetts
$5.82M -$760K -2,175 -10%
LG
330
Leuthold Group
Minnesota
$5.71M -$238K -681 -3%
CI Investments Inc
331
CI Investments Inc
Ontario, Canada
$5.61M +$1.11M +3,177 +21%
HEIP
332
Hudson Edge Investment Partners
New Jersey
$5.6M +$758K +2,170 +13%
VCA
333
Verdence Capital Advisors
Maryland
$5.6M -$1.5M -4,280 -19%
YIH
334
Y-Intercept (HK)
Hong Kong
$5.58M +$4.39M +12,571 +209%
LGF
335
LGT Group Foundation
Liechtenstein
$5.56M +$109K +312 +2%
KAM
336
Knightsbridge Asset Management
California
$5.51M -$7.69K -22 -0.1%
Thrivent Financial for Lutherans
337
Thrivent Financial for Lutherans
Minnesota
$5.5M -$422K -1,207 -6%
US Bancorp
338
US Bancorp
Minnesota
$5.47M +$337K +965 +6%
HFS
339
Hantz Financial Services
Michigan
$5.42M +$916K +2,621 +17%
A
340
AustralianSuper
Australia
$5.36M -$6.17M -17,643 -50%
EMPI
341
Elo Mutual Pension Insurance
Finland
$5.3M -$351K -1,005 -5%
QIM
342
Quantitative Investment Management
Virginia
$5.29M +$5M +14,314 +431%
WHG
343
Westwood Holdings Group
Texas
$5.27M
MSU
344
Mizuho Securities USA
New York
$5.19M +$1.83M +5,236 +43%
LS
345
Livforsakringsbolaget Skandia
Sweden
$5.16M -$34.9K -100 -0.6%
RIM
346
Redwood Investment Management
Arizona
$5.13M +$4.44M +12,697 +288%
AC
347
Asio Capital
Kentucky
$5.1M -$132K -378 -2%
Axa
348
Axa
France
$5.07M -$7.05M -20,175 -54%
TP
349
Tranquility Partners
Tennessee
$4.95M -$16.4K -47 -0.3%
Janney Montgomery Scott
350
Janney Montgomery Scott
Pennsylvania
$4.93M -$578K -1,655 -9%

HCA Hedge Fund Activity: Q4 2024 in Review

1,180 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in HCA Healthcare (HCA) for Q4 2024, worth a combined $47.7B — down 26% from $64.1B a quarter earlier.

Sellers outnumbered buyers: 149 funds closed out of HCA and 148 opened new positions — a net loss of 1 holder — while 468 trimmed existing stakes and 399 added.

The largest buyer was Qube Research & Technologies (QRT), adding an estimated $332M. The largest seller was Fidelity Investments, cutting an estimated $513M.

  • 1,180 institutional investors held HCA Healthcare (HCA) as of Q4 2024, down from 1,202 in Q3 2024.
  • Funds reported $47.7B of HCA Healthcare stock for Q4 2024, down 26% quarter-over-quarter.
  • 148 funds opened new HCA Healthcare positions in Q4 2024 and 149 closed out, a net change of -1 holder.
  • The largest HCA Healthcare buyer in Q4 2024 was Qube Research & Technologies (QRT), an estimated $332M added.
  • The largest HCA Healthcare seller in Q4 2024 was Fidelity Investments, an estimated $513M sold.

Based on aggregated 13F filings for Q4 2024.